BR112017015340A2 - uso de taurina na prevenção e/ou tratamento de doenças induzidas por vírus do gênero coronavírus e/ou gênero rotavírus - Google Patents

uso de taurina na prevenção e/ou tratamento de doenças induzidas por vírus do gênero coronavírus e/ou gênero rotavírus

Info

Publication number
BR112017015340A2
BR112017015340A2 BR112017015340-8A BR112017015340A BR112017015340A2 BR 112017015340 A2 BR112017015340 A2 BR 112017015340A2 BR 112017015340 A BR112017015340 A BR 112017015340A BR 112017015340 A2 BR112017015340 A2 BR 112017015340A2
Authority
BR
Brazil
Prior art keywords
coronavirus
taurine
prevention
treatment
diseases induced
Prior art date
Application number
BR112017015340-8A
Other languages
English (en)
Chinese (zh)
Other versions
BR112017015340B1 (pt
Inventor
Wang Yongdong
Cao Jiyuan
Zhu Shifa
Cheng Wen
Huang Zhipeng
Original Assignee
Genifarm Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genifarm Laboratories Inc filed Critical Genifarm Laboratories Inc
Publication of BR112017015340A2 publication Critical patent/BR112017015340A2/pt
Publication of BR112017015340B1 publication Critical patent/BR112017015340B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Fodder In General (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

a presente invenção fornece uso de taurina na prevenção e/ou tratamento de doenças induzidas por vírus do gênero coronavírus e/ou rotavírus, por exemplo, diarreia epidêmica porcina, gastroenterite transmissível porcina, diarreia por rotavírus e similares.
BR112017015340-8A 2015-01-17 2015-01-17 Uso de taurina na prevenção e/ou tratamento de doenças induzidas por vírus do gênero coronavírus e/ou gênero rotavírus BR112017015340B1 (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/CN2015/070953 WO2016112552A1 (zh) 2015-01-17 2015-01-17 牛磺酸在预防和/或治疗由冠状病毒属和/或轮状病毒属病毒引发的疾病中的应用

Publications (2)

Publication Number Publication Date
BR112017015340A2 true BR112017015340A2 (pt) 2018-01-09
BR112017015340B1 BR112017015340B1 (pt) 2022-10-11

Family

ID=56405151

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112017015340-8A BR112017015340B1 (pt) 2015-01-17 2015-01-17 Uso de taurina na prevenção e/ou tratamento de doenças induzidas por vírus do gênero coronavírus e/ou gênero rotavírus

Country Status (14)

Country Link
US (1) US10314799B2 (pt)
EP (1) EP3246024B1 (pt)
JP (1) JP6444515B2 (pt)
KR (1) KR101969007B1 (pt)
BR (1) BR112017015340B1 (pt)
CA (1) CA2974024C (pt)
DK (1) DK3246024T3 (pt)
ES (1) ES2758674T3 (pt)
MX (1) MX2017009343A (pt)
PH (1) PH12017550047A1 (pt)
PL (1) PL3246024T3 (pt)
RU (1) RU2678105C2 (pt)
UA (1) UA120066C2 (pt)
WO (1) WO2016112552A1 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109223716B (zh) * 2018-09-03 2020-10-30 北京普飞特生物科技有限公司 一种抗猪流行性腹泻、猪瘟、伪狂犬和传染性胃肠炎的四联卵黄抗体可溶性粉及其制备方法
IT202000012325A1 (it) * 2020-05-26 2021-11-26 Blueprint Pharma Srl Metotrexato per l’uso nel trattamento di infezioni virali in animali da allevamento
WO2021240375A1 (en) * 2020-05-26 2021-12-02 Blueprint Pharma S.R.L. Methotrexate for use in the pharmaceutical or veterinary prevention and/or treatment of viral infections
CN115350170B (zh) * 2022-08-29 2023-08-29 浙江省农业科学院 牛磺酸在制备提高中华鳖抗病毒性腮腺炎病能力的药物中的应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000044473A (ja) * 1998-07-27 2000-02-15 Mitsui Norin Co Ltd 家畜のウイルス感染予防剤
AU2003900064A0 (en) * 2003-01-09 2003-01-23 Penam Investments Pty. Ltd. A method of treatment or prophylaxis of viral infection.
KR100419191B1 (ko) * 2003-06-23 2004-02-19 주식회사 엔바이오테크놀러지 독감 인플루엔자 바이러스 및 전염성 위장염 코로나바이러스 억제 활성을 갖는 효모변이주 아이에스2 유래수용성 글루칸 올리고머를 함유하는 조성물
US7879030B2 (en) * 2005-07-27 2011-02-01 St. Jude Medical, Atrial Fibrillation Division, Inc. Multipolar, virtual-electrode catheter with at least one surface electrode and method for ablation
KR100720151B1 (ko) * 2005-12-13 2007-05-18 한국생명공학연구원 항바이러스 활성을 갖는 플라보노이드 화합물
CN101869151B (zh) * 2010-07-08 2012-07-04 湖南澳优食品与营养研究院 一种含乳凝集素的婴幼儿奶粉及其制备方法
CN101966245B (zh) 2010-10-13 2011-11-30 郑州后羿制药有限公司 一种治疗畜禽病毒性疾病的复方注射液及其制备方法
CN103006811B (zh) * 2012-12-29 2014-02-19 潍坊富邦药业有限公司 一种撒在初生仔猪的体表预防疾病的方剂及制备工艺
CN103341160B (zh) 2013-02-27 2015-11-11 澳蒲生物科技(上海)有限公司 一种含有干扰素的药物组合物及其应用
US9283250B2 (en) 2013-03-14 2016-03-15 Ag Odor Control, LLC Oral administration of electrolyzed water for treatment and prevention of PEDv in swine, swine herds and swine confinements
CN103127416B (zh) 2013-03-22 2014-11-26 刘荣彬 一种预防和治疗猪传染性胃肠炎和流行性腹泻的药物
CN103230574B (zh) 2013-04-25 2014-09-17 中国农业科学院兰州畜牧与兽药研究所 一种治疗猪流行性腹泻的中药组合物及其应用
CN103417570A (zh) 2013-08-30 2013-12-04 天津生机集团股份有限公司 用于治疗猪细菌腹泻的组合物及其制备方法

Also Published As

Publication number Publication date
US20170368006A1 (en) 2017-12-28
JP6444515B2 (ja) 2018-12-26
EP3246024B1 (en) 2019-09-25
BR112017015340B1 (pt) 2022-10-11
ES2758674T3 (es) 2020-05-06
RU2678105C2 (ru) 2019-01-23
RU2017125426A (ru) 2019-01-18
EP3246024A4 (en) 2018-10-24
PH12017550047B1 (en) 2018-02-05
PH12017550047A1 (en) 2018-02-05
PL3246024T3 (pl) 2020-03-31
KR20170106962A (ko) 2017-09-22
JP2018501294A (ja) 2018-01-18
CA2974024A1 (en) 2016-07-21
US10314799B2 (en) 2019-06-11
EP3246024A1 (en) 2017-11-22
DK3246024T3 (da) 2019-12-09
RU2017125426A3 (pt) 2019-01-18
UA120066C2 (uk) 2019-09-25
MX2017009343A (es) 2017-11-15
CA2974024C (en) 2020-01-21
KR101969007B1 (ko) 2019-04-15
WO2016112552A1 (zh) 2016-07-21

Similar Documents

Publication Publication Date Title
CO2018010458A2 (es) Composiciones y anticuerpos anti-tim-3
ECSP18089579A (es) Moduladores de la vía de estrés integrada
CO2017002170A2 (es) Terapia de combinación para tratar un paramixovirus
BR112018013995A2 (pt) terapia de combinação de vírus oncolítico e inibidor de ponto de verificação
CL2017000111A1 (es) Moléculas con especificidad para cd45 y cd79
CR20190350A (es) INHIBIDORES DE TGFß1 ISOFORMA-ESPECÍFICOS CONTEXTO-PERMISIVOS Y USO DE LOS MISMOS
BR112016024780A2 (pt) composições e métodos relacionados com construtos de fc manipulados
BR112017001162A2 (pt) métodos para tratar paramixovírus
AU2017240185A1 (en) Photosensitive dispersion and use thereof
BR112017002370A2 (pt) indóis para uso na infecção pelo vírus da gripe
CO2017002333A2 (es) Un artículo desechable que incluye por lo menos una región elástica unida
PH12016501873A1 (en) Anti-influenza b virus hemagglutinin antibodies and methods of use
BR112018074454A2 (pt) composições e métodos de uso de nintedanib para tratar doenças oculares com neovascularização anormal
BR112017004524A2 (pt) pirrolopirimidinas para uso na infecção pelo vírus da gripe
BR112018071048A2 (pt) combinações e métodos que compreendem um inibidor da montagem de capsídeos
EA201692541A1 (ru) Вакцины против вируса гриппа и их применения
BR112018015754A2 (pt) anticorpos anti-tnf, composições, métodos e uso para o tratamento ou prevenção de diabetes tipo 1
BR112018008103A2 (pt) análogos de celastrol
CO2018005393A2 (es) Anticuerpos anti-htra1 y métodos de uso de los mismos
PH12017550047B1 (en) Use of taurine in prevention and/or treatment of diseases induced by viruses of genus coronavirus and/or genus rotavirus
UY36187A (es) Anticuerpos antagonistas de interferón alfa y omega
BR112017011168A2 (pt) medicamentos para retardar a doença de parkinson
CL2018000228A1 (es) Nuevo antibiótico efectivo de aminoglucósido para bacterias resistentes a múltiples fármacos.
CL2017000378A1 (es) Métodos para tratar la depresión usando moduladores de nmda
UY36217A (es) Compuestos piridona sustituídos, composiciones farmacéuticas y métodos de uso.

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 17/01/2015, OBSERVADAS AS CONDICOES LEGAIS